Literature DB >> 28247153

Group B streptococcal PCR testing in comparison to culture for diagnosis of late onset bacteraemia and meningitis in infants aged 7-90 days: a multi-centre diagnostic accuracy study.

S M Morrissey1, M Nielsen1, L Ryan2, H Al Dhanhani3, M Meehan1, S McDermott4, N O'Sullivan3, M Doyle2, P Gavin3, N O'Sullivan3, R Cunney1, R J Drew5,6,7,8.   

Abstract

The aim of this study was to compare an in-house real-time PCR assay, with bacterial culture as the reference, for the diagnosis of late onset group B Streptococcal (GBS) disease. This was a retrospective review. All children aged 7-90 days presenting to four paediatric centres that had a blood or CSF sample tested by GBS PCR were included. Of 7,686 blood and 2,495 cerebrospinal fluid (CSF) samples from patients of all ages received for PCR testing, 893 and 859 samples were eligible for the study, respectively. When compared to culture, the sensitivity of blood PCR was 65% (13/20) in comparison to the CSF PCR test which was 100% (5/5). Ten of 23 PCR-positive blood samples and 17 of 22 PCR-positive CSF samples were culture negative. The median threshold Ct values for culture-positive/PCR-positive CSF samples was lower than that of culture-negative/PCR-positive CSF samples (p = 0.08). Clinical details of 17 available cases that were culture negative/PCR positive were reviewed; seven were deemed to be definite cases, eight were probable and two were possible. The results showed that detection of GBS by PCR is useful for CSF samples from infants aged 7-90 days with suspected meningitis; however, analysis of blood samples by PCR is of limited value as a routine screening test for late onset GBS sepsis and should not replace bacterial culture.

Entities:  

Mesh:

Year:  2017        PMID: 28247153     DOI: 10.1007/s10096-017-2938-3

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  15 in total

1.  The Protective Value of Maternal Group B Streptococcus Antibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular Polysaccharides and Pilus Proteins in European Maternal Sera.

Authors:  Monica Fabbrini; Fabio Rigat; C Daniela Rinaudo; Irene Passalaqua; Sceida Khacheh; Roberta Creti; Lucilla Baldassarri; Filippo Carboni; Giulia Anderloni; Roberto Rosini; Domenico Maione; Guido Grandi; John L Telford; Immaculada Margarit
Journal:  Clin Infect Dis       Date:  2016-07-11       Impact factor: 9.079

Review 2.  Molecular assays in the diagnosis of neonatal sepsis: a systematic review and meta-analysis.

Authors:  Mohan Pammi; Angela Flores; Mariska Leeflang; James Versalovic
Journal:  Pediatrics       Date:  2011-09-26       Impact factor: 7.124

3.  Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis.

Authors:  S J Schrag; S Zywicki; M M Farley; A L Reingold; L H Harrison; L B Lefkowitz; J L Hadler; R Danila; P R Cieslak; A Schuchat
Journal:  N Engl J Med       Date:  2000-01-06       Impact factor: 91.245

4.  Non-culture detection of Streptococcus agalactiae (Lancefield group B Streptococcus) in clinical samples by real-time PCR.

Authors:  Aruni de Zoysa; Kirstin Edwards; Saheer Gharbia; Anthony Underwood; André Charlett; Androulla Efstratiou
Journal:  J Med Microbiol       Date:  2012-06-26       Impact factor: 2.472

5.  Real-time polymerase chain reaction and culture in the diagnosis of invasive group B streptococcal disease in infants: a retrospective study.

Authors:  M Meehan; M Cafferkey; S Corcoran; A Foran; N Hapnes; D LeBlanc; C McGuinness; U Nusgen; N O'Sullivan; R Cunney; R Drew
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-10-03       Impact factor: 3.267

6.  Incidence, etiology, and outcome of bacterial meningitis in infants aged <90 days in the United kingdom and Republic of Ireland: prospective, enhanced, national population-based surveillance.

Authors:  Ifeanyichukwu O Okike; Alan P Johnson; Katherine L Henderson; Ruth M Blackburn; Berit Muller-Pebody; Shamez N Ladhani; Mark Anthony; Nelly Ninis; Paul T Heath
Journal:  Clin Infect Dis       Date:  2014-07-04       Impact factor: 9.079

7.  Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial.

Authors:  Shabir A Madhi; Clare L Cutland; Lisa Jose; Anthonet Koen; Niresha Govender; Frederick Wittke; Morounfolu Olugbosi; Ajoke Sobanjo-Ter Meulen; Sherryl Baker; Peter M Dull; Vas Narasimhan; Karen Slobod
Journal:  Lancet Infect Dis       Date:  2016-04-29       Impact factor: 25.071

8.  Accuracy of a rapid real-time polymerase chain reaction assay for diagnosis of group B Streptococcus colonization in a cohort of HIV-infected pregnant women.

Authors:  Maria Isabel S Gouvea; Esau C Joao; Maria de Lourdes B Teixeira; Jennifer S Read; Sergio E L Fracalanzza; Claudia T V Souza; Maria José de Souza; Helio M Torres Filho; Cassiana C F Leite; Pedro E A A do Brasil
Journal:  J Matern Fetal Neonatal Med       Date:  2016-07-15

Review 9.  An overview of global GBS epidemiology.

Authors:  Kirsty Le Doare; Paul T Heath
Journal:  Vaccine       Date:  2013-08-28       Impact factor: 3.641

10.  Development and performance evaluation of a recombinase polymerase amplification assay for the rapid detection of group B streptococcus.

Authors:  Christina Clarke; Louise O'Connor; Heather Carré-Skinner; Olaf Piepenburg; Terry J Smith
Journal:  BMC Microbiol       Date:  2016-09-22       Impact factor: 3.605

View more
  9 in total

Review 1.  Group B Streptococcal Neonatal Meningitis.

Authors:  Teresa Tavares; Liliana Pinho; Elva Bonifácio Andrade
Journal:  Clin Microbiol Rev       Date:  2022-02-16       Impact factor: 50.129

2.  Towards accurate exclusion of neonatal bacterial meningitis: a feasibility study of a novel 16S rDNA PCR assay.

Authors:  Arthur Abelian; Thomas Mund; Martin D Curran; Stuart A Savill; Nipa Mitra; Carol Charan; Amanda L Ogilvy-Stuart; Hugh R B Pelham; Paul H Dear
Journal:  BMC Infect Dis       Date:  2020-06-22       Impact factor: 3.090

3.  Disease burden of neonatal invasive Group B Streptococcus infection in the Netherlands.

Authors:  Brechje de Gier; Merel N van Kassel; Elisabeth A M Sanders; Diederik van de Beek; Susan J M Hahné; Arie van der Ende; Merijn W Bijlsma
Journal:  PLoS One       Date:  2019-05-09       Impact factor: 3.240

4.  Clinical characteristics and molecular epidemiology of children with meningitis in Tehran, Iran: a prospective study.

Authors:  A Pormohammad; S Lashkarbolouki; T Azimi; P Gholizadeh; N Bostanghadiri; H Safari; S Armin; N Mohtavinejad; F Fallah
Journal:  New Microbes New Infect       Date:  2019-08-29

5.  Multiplex Droplet Digital Polymerase Chain Reaction Assay for Rapid Molecular Detection of Pathogens in Patients With Sepsis: Protocol for an Assay Development Study.

Authors:  Samir Badran; Ming Chen; John E Coia
Journal:  JMIR Res Protoc       Date:  2021-12-13

6.  Case Report: Prolonged CSF PCR Positivity in a Neonate With GBS Meningitis.

Authors:  Nourah Alruqaie; Yara Falatah; Fawaz Alzahrani; Musaed Alharbi
Journal:  Front Pediatr       Date:  2021-11-25       Impact factor: 3.418

Review 7.  Neonatal Meningitis: Overcoming Challenges in Diagnosis, Prognosis, and Treatment with Omics.

Authors:  Scott M Gordon; Lakshmi Srinivasan; Mary Catherine Harris
Journal:  Front Pediatr       Date:  2017-06-16       Impact factor: 3.418

8.  Enhanced identification of Group B streptococcus in infants with suspected meningitis in Ethiopia.

Authors:  Alene Geteneh; Tesfaye Kassa; Yared Alemu; Derbie Alemu; Mulugeta Kiros; Henok Andualem; Workeabeba Abebe; Tinsae Alemayehu; Dawit Hailu Alemayehu; Adane Mihret; Andargachew Mulu; Wude Mihret
Journal:  PLoS One       Date:  2020-11-19       Impact factor: 3.240

9.  Pediatric sepsis cases diagnosed with group B streptococcal meningitis using next-generation sequencing: a report of two cases.

Authors:  Kazuhiro Horiba; Michio Suzuki; Nobuyuki Tetsuka; Yoshihiko Kawano; Makoto Yamaguchi; Toshihiko Okumura; Takako Suzuki; Yuka Torii; Jun-Ichi Kawada; Makoto Morita; Shinya Hara; Tomoo Ogi; Yoshinori Ito
Journal:  BMC Infect Dis       Date:  2021-06-05       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.